Hormone therapy and cardiovascular disease-are we back to the beginning?

Climacteric

Volumn 18, Issue 4, 2015, Pages 437-438

  Fenton, Anna ^a   Panay, Nick ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROGESTERONE;

AGE; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; EDITORIAL; ESTROGEN THERAPY; FEMALE; HEART DISEASE; HEART INFARCTION; HORMONAL THERAPY; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; AGED; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; MIDDLE AGED; MORTALITY; PROCEDURES;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED;

EID: 84932093302     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2015.1057958     Document Type: Editorial

References (10)

1. Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015 Mar 10;3: CD002229. doi: 10.1002/14651858.CD002229.pub4
2. Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women ' s Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33
3. Anderson G L, Limacher M, Assaf A R, et a l. W omen ' s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women ' s Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-12
4. Schierbeck L, Rejnmark L, Tofteng C. et al. H ormone replacement treatment in early postmenopausal women reduces cardiovascular events-A randomized controlled study. Circulation 2011; 124: A11380
5. Salpeter SR, Walsh JME, Greyber E, Salpeter EE. Coronary heart disease events associated with hormone therapy in younger and older women. J Gen Intern Med 2006; 21: 363-6
6. Harman S M, Brinton E A, Cedars M, et a l. K EEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005; 8: 3-12
7. Harman S M, Black D M, Naftolin F, et al. A rterial imaging outcomes and cardiovascular risk factors in recently menopausal women: A randomized trial. Ann Intern Med 2014; 161: 249-60
8. Hodis H N, Mack W J, Shoupe D, et al. T esting the menopausal hormone therapy timing hypothesis: The Early Vs Late Intervention Trial with Estradiol. Circulation 2014; 130: A13283
9. de Villiers T J, Gass M LS, Haines C J, et a l. G lobal Consensus Statement on Menopausal Hormone Therapy. Climacteric 2013; 16: 203-4
10. Roberts H, Hickey M. S hould hormone therapy be recommended for prevention of cardiovascular disease?[editorial]. Cochrane Database Syst Rev 2015; (3): 10.1002/14651858.ED000097